Southernsun Asset Management LLC increased its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 10.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 547,111 shares of the company’s stock after purchasing an additional 52,062 shares during the quarter. U.S. Physical Therapy makes up about 5.5% of Southernsun Asset Management LLC’s portfolio, making the stock its 7th largest holding. Southernsun Asset Management LLC owned about 3.62% of U.S. Physical Therapy worth $46,302,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. State Street Corp increased its holdings in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares during the period. Renaissance Technologies LLC grew its position in shares of U.S. Physical Therapy by 763.7% in the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after buying an additional 61,474 shares during the last quarter. Penn Davis Mcfarland Inc. acquired a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $2,552,000. Rockefeller Capital Management L.P. raised its position in shares of U.S. Physical Therapy by 18.8% during the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after acquiring an additional 25,393 shares during the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in shares of U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after acquiring an additional 12,445 shares during the period.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the stock. Bank of America restated a “neutral” rating and set a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Barrington Research reissued an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st.
Insider Transactions at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the transaction, the director now owns 1,112 shares in the company, valued at approximately $107,552.64. The trade was a 51.31 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Eric Joseph Williams sold 2,000 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $95.84, for a total value of $191,680.00. Following the completion of the sale, the insider now directly owns 14,814 shares of the company’s stock, valued at approximately $1,419,773.76. This trade represents a 11.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,896 shares of company stock valued at $656,940 in the last 90 days. 1.70% of the stock is currently owned by corporate insiders.
U.S. Physical Therapy Stock Performance
NYSE:USPH opened at $97.62 on Friday. The firm has a market capitalization of $1.47 billion, a P/E ratio of 103.85, a P/E/G ratio of 4.48 and a beta of 1.46. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The company has a fifty day moving average of $87.80 and a 200-day moving average of $90.36. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.
U.S. Physical Therapy Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.44 per share. The ex-dividend date is Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.80%. U.S. Physical Therapy’s dividend payout ratio is currently 187.23%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- 3 Stocks to Consider Buying in October
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- 3 Best Fintech Stocks for a Portfolio Boost
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.